It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
CHICAGO (AP) -- For the second time in two months, the Journal of the American Medical Association says it was misled by researchers who failed to reveal financial ties to drug companies.
Dr. Jerome Kassirer, a former New England Journal of Medicine editor and an outspoken critic of doctors' conflicts of interest, said it would be impossible for medical journals to reject all research with industry ties.
If industry ties were an obstacle to getting research published, "you'd have no research on drugs," Kassirer said.
Still, industry-funded drug research tends to have more favorable results than other studies, and those ties need to be revealed so readers can have "a healthy skepticism," he said.
The New England Journal of Medicine also requires financial disclosures from authors, although not before accepting an article for publication as JAMA is now doing, said Dr. Jeffrey Drazen, the journal's editor.
The Center for Science in the Public Interest recommended Tuesday that editors adopt a three-year ban from publishing in their journals in failure-to-disclose cases.
But Drazen and DeAngelis said that would be impractical and unnecessary.
"Editors have very long institutional memories," Drazen said. "I think that's adequate in this case."
CHICAGO (AP) -- Just days after announcing a crackdown on researchers who do not disclose drug company ties, the editor of a prestigious medical journal says she was misled again - this time by the authors of a study linking severe migraines to heart attacks in women.
"I suspect we are going to have a whole bunch of disclosures over the next few weeks because authors are going to see how dead serious we are," DeAngelis said.